AbbVie reports more solid data for would-be psoriasis blockbuster | www.pmlive.com

“Psoriasis ‘blockbuster’ requires more solid data”, as AbbVie report


Risankizumab showed to be more effective in plaque psoriasis patients than J&J’s Stelara


Source: AbbVie reports more solid data for would-be psoriasis blockbuster

Shared by www.pmgrouplive.com/


AbbVie HOME PAGE  >>> www.abbvie.com/




 

Advertisements